Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/A1RG34 stock hub

BVMF/A1RG34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/A1RG34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

240.5B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/A1RG34

In the news

Latest news · BVMF/A1RG34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25

P25 11.3P50 14.6P75 19.6

Trailing P/E31

P25 15.2P50 21.5P75 27.3

ROEn/a

P25 5.3P50 12.3P75 22.5

ROIC44.3

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/A1RG34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

149

Groups with data

Currency

USD

Showing 149 of 149 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	BR
Employees	1,863
Employees Change	451%
Employees Change Percent	39.29
Enterprise value	BRL 218.5B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	BRL 240.5B
Price	BRL 155
Price currency	BRL
Rev Per Employee	13,279,740.52x
Sector	Healthcare
Sic	2836
Symbol	bvmf/A1RG34
Website	https://argenx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.23%
EV Earnings	28.13x
EV/EBIT	33.69x
EV/EBITDA	33.2x
EV/Sales	9.22x
Forward P/E	25.02x
P/B ratio	6.29x
P/E ratio	30.96x
P/S ratio	9.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.61%
EBITDA Margin	27.8%
Gross margin	58.11%
Gross Profit	BRL 14.4B
Gross Profit Growth	110.26%
Gross Profit Growth Q	79.4%
Net Income	BRL 7.8B
Net Income Growth	39.93%
Net Income Growth Q	115.97%
Pretax Margin	31.68%
Profit Margin	31.4%
Profit Per Employee	BRL 4.2M
Roa5y	-4.42
Roe5y	-3.39
ROIC	44.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.78%
Cagr3y	24.79%
EPS Growth	41.13
EPS Growth Q	114
Revenue Growth	79.43x
Revenue Growth Q	62.63x
Revenue Growth3 Y	95.02x
Revenue Growth5 Y	87.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	BRL 23.2B
Debt	BRL 246M
Debt EBITDA	BRL 0.04
Debt Equity	BRL 0.01
Equity	BRL 38.2B
Interest Coverage	412.5
Net Cash	BRL 22.9B
Net Cash By Market Cap	BRL 9.53
Net Cash Growth	31.53%
Net Debt EBITDA	BRL -3.33
Net Debt Equity	BRL -0.6
Tangible Book Value	BRL 36.8B
Tangible Book Value Per Share	BRL 594
WACC	3.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.77%
200-day SMA	154.5
3Y total return	94.34%
50-day SMA	173.8
50-day SMA vs 200-day SMA	50over200
All Time High	200.2
All Time High Change	-22.83%
All Time High Date	2025-11-26
All Time Low	64.19
All Time Low Change	140.69%
All Time Low Date	2022-11-30
ATR	4.3
Beta	-0.06
Ch YTD	-17.73
High	154.5
High52	200.2
High52 Date	2025-11-26
High52ch	-22.83%
Low	154.5
Low52	116.9
Low52 Date	2025-06-30
Low52ch	32.19%
Ma50ch	-11.1%
Price vs 200-day SMA	-0.01%
RSI	42.05
RSI Monthly	54.63
RSI Weekly	47.17
Sharpe ratio	1.44x
Sortino ratio	2.63
Total Return	0.85%
Tr YTD	-17.73
Tr1m	0.39%
Tr1w	-1.55%
Tr3m	-13.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 6.8B
Operating Income Growth	509
Operating Income Growth Q	178.9
Operating margin	27.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,086,042%
Shares Insiders	0.16%
Shares Institutions	74.66%
Shares Qo Q	-0.11%
Shares Yo Y	-0.85%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	332.5x
Bv Per Share	617.3
Ch1m	0.39
Ch1w	-1.55
Ch1y	9.77
Ch3m	-13.56
Ch3y	94.34
Ch6m	-8.58
Change	0%
Change From Open	0
Depreciation Amortization	42,631,913.6
Dollar Volume	95,790
Earnings Date	2026-05-07
EBIT	BRL 6.8B
EBITDA	BRL 6.9B
EPS	BRL 117
F Score	2
Fiscal Year End	December
Founded	2,008
Graham Number	52.49894
Graham Upside	-66.02
Income Tax	BRL 70.8M
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	157.3
Ma150ch	-1.76%
Ma20	160.6
Ma20ch	-3.78%
Next Earnings Date	2026-07-23
Open	154.5
Price Date	2026-05-07
Price EBITDA	BRL 34.97
Ptbv Ratio	6.54
Relative Volume	1.86x
Revenue	24,740,156,594x
Tax By Revenue	0.29x
Tax Rate	0.9%
Tr6m	-8.58%
Volume	620

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/A1RG34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/A1RG34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/A1RG34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+74.7%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

BVMF/A1RG34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

-0.0%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/A1RG34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/A1RG34 stock rating?

bvmf/A1RG34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/A1RG34 analysis?

The full report lives at /stocks/bvmf/A1RG34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/A1RG34?

The latest report frames bvmf/A1RG34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/A1RG34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.